Mounjaro, the breakthrough obesity and diabetes drug from Eli Lilly and Company, has become India’s highest-selling pharmaceutical brand in October, according to fresh data from
‘Talking’ to cells without influencing genes or molecules: it can be done by influencing bioelectric fields. By manipulating the bioelectric fields in organisms like planaria
The Indian pharmaceutical industry’s defining trend currently is the shift from volume-led growth to value- and innovation-led expansion. Indian companies are investing significantly in R&D,
There is a need to redefine Glucagon-Like Peptide-1 (GLP-1) therapy to adopt metabolism first path towards diabetes care, says Hummsa Biotech founder Harshad Lalwani.“Biotechnology company,
A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined
German pharmaceutical giant Bayer plans to adopt a strong tiered pricing approach worldwide to make its drugs and therapies affordable. However, Stefan Oelrich, head of
Merck, known as MSD outside of the United States and Canada, announced the presentation of findings from a systematic literature review of studies on the
The Drugs Control Administration (DCA) in Telangana has cracked down on the illegal sale of the potent cardiac stimulant, mephentermine sulphate injection, following a raid
As federal workers face mass layoffs and a government shutdown, Dr. Frances Oldham Kelsey’s story is a reminder of what public servants can do when
The analyst said SMS Pharmaceuticals is showing a technically strong setup, with rising momentum, improving volumes, and consistent strength across daily, weekly, and monthly charts.SMS
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump